Gastroenterology

Gastroenterology

Volume 160, Issue 5, April 2021, Pages 1886-1887
Gastroenterology

Correspondence
Reply

https://doi.org/10.1053/j.gastro.2021.01.020Get rights and content

Cited by (0)

Conflicts of interest The authors have made the following disclosures: Erica J. Brenner reports no conflicts of interest. Ryan C. Ungaro reports grant support from an NIH K23 Career Development Award (K23KD111995-01A1); has served as an advisory board member or consultant for Eli Lilly, Janssen, Pfizer, and Takeda; and receives research support from AbbVie, Boehringer Ingelheim, and Pfizer. Dr Colombel reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development, and Genfit. Michael D. Kappelman has consulted for Abbvie, Janssen, and Takeda, is a shareholder in Johnson & Johnson, and has received research support from Abbvie and Janssen.

Authors share co-first authorship.

View Abstract